The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma-Reference-Cited by-同舟云学术

The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma

Published:2016-03-16 Issue:1 Volume:9 Page:
ISSN:1756-8722
Container-title:Journal of Hematology & Oncology
language:en
Short-container-title:J Hematol Oncol

Author:

La Nasa Giorgio,Greco Marianna,Littera Roberto,Oppi Sara,Celeghini Ivana,Caria Rossella,Lai Sara,Porcella Rita,Martino Massimo,Romano Alessandra,Di Raimondo Francesco,Gallamini Andrea,Carcassi Carlo,Caocci Giovanni

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Biology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/s13045-016-0255-4

Reference31 articles.

1. Diefenbach C, Advani R. Customized targeted therapy in Hodgkin lymphoma: hype or hope? Hematol Oncol Clin North Am. 2014;28:105–22.

2. Gallamini A, Barrington SF, Biggi A, Chauvie S, Kostakoglu L, Gregianin M, et al. The predictive role of interim positron emission tomography on Hodgkin lymphoma treatment outcome is confirmed using the 5-point scale interpretation criteria. Haematologica. 2014;99:1107–13.

3. Scott DW, Steidl C. The classical Hodgkin lymphoma tumor microenvironment: macrophages and gene expression-based modeling. ASH Education Book. 2014;1:144–50.

4. Romano A, Vetro C, Caocci G, Greco M, Parrinello NL, Di Raimondo F, et al. Immunological deregulation in classic Hodgkin lymphoma. Mediterr J Hematol Infect Dis 2014; e2014039. doi: 10.4084/MJHID.2014.039 .

5. Visser L, Van den Berg A, Poppema S, Diepstra A. Microenvironment, cross-talk, and immune escape mechanisms. In: Engert A, Horning SJ, editors. Hodgkin lymphoma: a comprehensive update on diagnostics and clinics. Berlin: Springer Verlag; 2011. p. 49–58.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation;Scientific Reports;2024-09-09

2. KIR Genotypes Impact Progression to Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Infection;Livers;2023-07-31

3. Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia;Blood Advances;2023-06-28

4. Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin Lymphoma;Frontiers in Immunology;2022-01-27

5. Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk;Scientific Reports;2021-04-12